> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-175/
- Published: 2018-04-15T12:00:00.000Z
- Updated: 2026-09-14T23:59:04.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141227

[**Panel to Review Siga Tech Smallpox NDA**](https://www.fdaweb.com/panel-to-review-siga-tech-smallpox-nda/)  
*Federal Register* notice: FDA announces a 5/1 Antimicrobial Drugs Advisory Committee meeting to discuss a Siga Technologies NDA for tecovirimat. 04/13/2018

[**Info Collection Extension on Dispute Resolution**](https://www.fdaweb.com/info-collection-extension-on-dispute-resolution/)  
*Federal Register* notice: FDA submits for OMB approval an information collection extension for its “Guidance for Industry on Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice.” 04/13/2018

[**Info Collection Extension for Accredited Persons Inspections**](https://www.fdaweb.com/info-collection-extension-for-accredited-persons-inspections/)  
*Federal Register* notice: FDA submits to OMB for approval an information collection extension for “Notification of the Intent To Use An Accredited Person Under the Accredited Persons Inspection Program.” 04/13/2018

[**ICH Addendum to Pediatric Trial Guide**](https://www.fdaweb.com/ich-addendum-to-pediatric-trial-guide/)  
*Federal Register* notice: FDA makes available a guidance entitled “E11(R1) Addendum: Clinical Investigation of Medicinal Products in the Pediatric Population.” 04/12/2018

[**18 ANDAs No Longer Marketed are Withdrawn** ](https://www.fdaweb.com/18-andas-no-longer-marketed-are-withdrawn/)*Federal Register* notice: FDA withdraws approval of 18 ANDAs from multiple applicants. 04/12/2018

[**Reagan-Udall Foundation Annual Meeting 5/4**](https://www.fdaweb.com/reagan-udall-foundation-annual-meeting-5-4/)  
*Federal Register* notice: FDA announces a 5/4 Reagan-Udall Foundation annual public meeting to discuss its activities and how it supports the agency. 04/12/2018

[**Consumer Reps Sought for Advisory Committees**](https://www.fdaweb.com/consumer-reps-sought-for-advisory-committees/)  
*Federal Register* notice: FDA seeks the participation of consumer organizations in the selection of voting and nonvoting consumer representatives to serve on its advisory committees or panels.04/11/2018

[**Comments Sought on Dietary Supplement Identity Tests**](https://www.fdaweb.com/comments-sought-on-dietary-supplement-identity-tests/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for “Petition To Request an Exemption From 100% Identity Testing of Dietary Ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements.” 04/11/2018

[**Info Collection Extension on Condom Labeling**](https://www.fdaweb.com/info-collection-extension-on-condom-labeling/)  
*Federal Register* notice: FDA submits for OMB approval an information collection extension for “Class 2 Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms — 21 CFR 884.5300.” 04/10/2018